The Cannigma

JUNE 21, 2025

While unique to cannabis, trace amounts of THC can also be found in hemp, and are even made into the synthetic version of THC in the pharmaceutical drug Marinol. As the primary cannabinoid responsible for both the therapeutic benefits and psychoactive effects of cannabis, THC has been the focus of extensive scientific research.

Cannabinoids 104

Cannabinoids Sleep Blood Pressure THC 104

Veriheal

JUNE 10, 2025

This passage also spurred the development of an eagerly anticipated psychedelic-assisted therapy industry, now ready to see its very first patients very soon. Existing wellness and therapy centers can apply for a micro-healing center license that can integrate psychedelic-assisted therapy into their offerings for their patients.

Therapy 59

Therapy Medicine Programs Treatment 59

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”

Clinical Trials 268

Clinical Trials Chronic Pain Cannabinoids Patients 268

Veriheal

OCTOBER 3, 2022

With the growing acceptance and legalization of cannabis, the pharmaceutical industry is taking serious hits, according to a 2022 novel study into the impact of cannabis legalization on pharmaceutical firms. What Is the Pharmaceutical Industry? pharmaceuticals). Still, most pharmaceuticals are heavily processed.

Pharmaceutical 105

Pharmaceutical Patients Research and Development Legalization 105

NORML

FEBRUARY 14, 2019

SB1719 allows “registered agents” for those patients physically unable to pick up or receive delivery of their medical cannabis, like those in hospice, assisted living facilities, and those who rely on home healthcare providers. Virginia NORML members meet with Senator Dave Marsden. “I am proud to be part of this effort.”

Access 199

Access Patients Legislation Medicine 199

United Patients Group

MARCH 15, 2023

The following are some examples of how cannabis can help patients taper off other drugs: Cannabis is a natural treatment for pain and other symptoms of withdrawal. Patients who are prescribed these medications may find that using cannabis helps them to sleep better at night and feel more relaxed during the day.

Pharmaceutical 98

Pharmaceutical Patients Chronic Pain Sleep 98

Americans for Safe Access

AUGUST 12, 2024

A letter from ASA Founder & President The positive impacts of medical cannabis on patients and the healthcare systems that serve them are profound and far-reaching. territories, often serving as a crucial alternative when conventional treatments have failed or as a safer option compared to pharmaceuticals.

Therapy 261

Therapy Pharmaceutical Treatment Programs 261

LifeCannMD

JANUARY 2, 2025

#image_title Medical Marijuana vs. Traditional Pharmaceuticals: A Patient’s Guide to Understanding Your Options When discussing Medical Marijuana for managing chronic pain , Dr. Fernando Fandio-Sende has fielded many questions. Miami patients often ask how it compares to traditional medications they have been taking for years.

Pharmaceutical 98

Pharmaceutical Chronic Pain Marijuana Blood Pressure 98

CannaMD

AUGUST 4, 2022

As medical marijuana continues to gain acceptance across the United States and beyond, patients are increasingly turning to cannabis-based therapies as a complement or alternative to prescription pharmaceutical drugs.

Patients 141

Patients Therapy Pharmaceutical Marijuana 141

Veriheal

AUGUST 12, 2021

Patients who suffer from epilepsy , which affects some 3.4 Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC.

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Cannabis Law Report

SEPTEMBER 2, 2021

Research on the endocannabinoid system is one of the most promising avenues for new therapeutics in medicine at the moment, however regulations are constantly shifting beneath the feet of operators and their ability to serve patients depends on their capacity to navigate a changing landscape of governance.

Pharmaceutical 105

Pharmaceutical Clinical Trials Research and Development Cannabinoids 105

Veriheal

APRIL 11, 2022

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. Pennsylvania-based Groff North America is one of the companies that is getting a green light to experiment with the plant. territories.

Pharmaceutical 106

Pharmaceutical Research and Development DEA Clinical Trials 106

CannaMD

NOVEMBER 8, 2021

In recognition of this information, a significant but still limited number of Parkinson’s patients have turned to cannabis as a complementary therapy to traditional pharmaceutical options. A survey of current […].

Patients 105

Patients Therapy Pharmaceutical Marijuana 105

NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”

Law 257

Law Patients Access Oil 257

Project CBD

NOVEMBER 11, 2023

In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. I have many patients that want to use cannabis, and they who ask me what product should they get? I include pharmaceutical drugs in that category. Cannabis is a really special case.

Medicine 309

Medicine Research and Development Pharmaceutical Cannabis 309

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

JUNE 17, 2021

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. regulatory approval, and our new cannabinoid research platform,” said Renée Galá, the chief financial officer of Jazz Pharmaceuticals.

Pharmaceutical 83

Pharmaceutical Clinical Trials Therapy Programs 83

FloridaMarijuana.net

AUGUST 16, 2018

Dementia cannot be confirmed until a patient is deceased. Dementia is hard on the patient, and often harder on the family or caregivers. Pharmaceutical treatments for for Dementia often only target symptoms like pain or depression, but those medicines do not cure or prevent the disease. 9-tetrahydrocannabinol (?9-THC)

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

Veriheal

JULY 26, 2023

Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. Eligible patients registered with the state’s Department of Public Health can purchase cannabis oil from Georgia’s independent pharmacies.

Oil 98

Oil Patients Access THC 98

NORML

JUNE 13, 2019

Millions of Americans are legally replacing pharmaceuticals with cannabis and the question of affordability has become critical. Price caps that could favor seriously ill patients/consumers will be an entirely new concept to the cannabis industry, but it’s no innovation. Are you paying too much for medical marijuana?

Marijuana 277

Marijuana Dispensary Patients Retail 277

The Cannigma

SEPTEMBER 21, 2021

There are cannabis users, patients, and just everyday fans who may be fans, but don’t make it a big part of their public persona. For these famous medical cannabis patients and supporters, it is something that can improve quality of life and which should be made readily available to anyone in need. 1) Patrick Stewart. It’s tricky.”.

Patients 128

Patients Research and Development Sleep Clinical Trials 128

Veriheal

APRIL 7, 2022

The study’s researchers, who voiced concern about the current pharmaceutical treatment for MS, looked at the neurological benefits, clinical challenges, and neuropathologic promise of medical cannabis for MS. In a survey of 5,481 MS patients, 47% considered using MMJ, but only 20% spoke with their physician about it.

Patients 98

Patients Treatment Cannabinoids Pharmaceutical 98

Cannabis Cheri

DECEMBER 17, 2021

Locate a nurse and ask how many patients are in the respiratory wing due to their use of tobacco. You will learn that most of the patients in that wing are there for that reason. Now ask how many patients are there because they only smoked marijuana. This article is all about the effects of marijuana on the lungs.

Marijuana 247

Marijuana Media Patients DEA 247

NORML

AUGUST 26, 2019

Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business.

Legalization 235

Legalization Marijuana Programs Oil 235

Cannabis Law Report

AUGUST 27, 2021

The Edmonton, Alberta-based cannabis giant also said that its subsidiary and Ethypharm were selected by the National Agency for the Safety of Medicines and Health Products to supply the entire medical cannabis dried flower range sourced from the company’s EU GMP facility in Denmark Aurora Nordic to French patients as part of the program.

Patients 105

Patients Programs Pharmaceutical Compliance 105

Cannabis Law Report

AUGUST 22, 2021

“The Janus particle solution will allow for time-released and combined therapies to be administered to patients, targeting specific indications. is using cutting-edge delivery technologies to develop safe and effective psychedelic pharmaceutical medicines. ” About Psycheceutical, Inc. Psycheceutical, Inc.

Pharmaceutical 98

Pharmaceutical Medicine Research and Development Therapy 98

FloridaMarijuana.net

JUNE 22, 2018

Patients who suffer from this condition also face other symptoms that are painful, inconvenient -to say the least, -and lower their quality of life. An article published on the marijuanadoctor.com website discusses the best strains of marijuana for patients with IBS.

Hybrid 190

Hybrid Marijuana Sativa Patients 190

FloridaMarijuana.net

JULY 5, 2018

Patients often report feeling relief almost immediately. This strain is known to increase energy and a creative flow in patients; some report even feeling more focused and productive. This is not the strain for patients who suffer from insomnia which is why most patients find this strain to be most effective for daytime use.

Strains 190

Strains Chronic Pain Indica Hybrid 190

Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. In both Europe and the United States, the sales of unapproved cannabis products such as smokable flower and full spectrum oils dwarf those of approved pharmaceuticals.

Pharmaceutical 74

Pharmaceutical Clinical Trials Research and Development Cannabinoids 74

NORML

MARCH 14, 2019

A retrospective review of patients’ symptoms published in 2014 in the Journal of Psychoactive Drugs reported a greater than 75 percent reduction CAPS (Clinician Administered Post-traumatic Scale) symptom scores following cannabis therapy. Send a message now to your lawmakers.

Access 230

Access Chronic Pain Treatment Conditions 230

NORML

FEBRUARY 23, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. It would not allow patients to smoke herbal marijuana or vape, but would allow forms including pills, oils, lozenges and patches.

Legislation 252

Legislation Patients Decriminalization Access 252

Veriheal

SEPTEMBER 7, 2022

’s medical cannabis program come on the heels of a previously enacted emergency amendment focused on senior citizens: The Medical Marijuana Patient Access Extension Emergency Amendment Act of 2022 allowed D.C. A Temporary Triumph for Medical Cannabis Patients. The State of Patients’ Rights and Access in America Today.

Patients 98

Patients Programs Access Treatment 98

Cannabis Law Report

JULY 7, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Current TNF-a inhibitors available today, while effective, come with an array of adverse effects and concerns for patients,” said Adam Kaplin, M.D., About MyMD Pharmaceuticals, Inc. Company plans to initiate Phase II trial with a leading academic institution.

Pharmaceutical 81

Pharmaceutical Data Clinical Trials Research and Development 81

Cannabis Law Report

JUNE 10, 2021

–(BUSINESS WIRE)– CURE Pharmaceutical Holding Corp. We’ve been working to develop safe, accurately-dosed cannabis solutions for several years now and we believe that this collaboration will help us take that initiative to the next level and expand our reach,” said Rob Davidson, CURE Pharmaceutical CEO. OXNARD, Calif.–(BUSINESS

Pharmaceutical 75

Pharmaceutical DEA Research and Development THC 75

Cannabis Law Report

JUNE 23, 2021

Valcon Medical A/S Announces Receipt of EU GMP Certification and Start of Commercial Production for Pharmaceutical-Grade Cannabis Concentrates, Intermediary Products, and Medical Formulations (PRNewsfoto/Valcon Medical A/S).

Pharmaceutical 86

Pharmaceutical Concentrates Extraction Medicine 86

NORML

JANUARY 24, 2019

It seeks to redefine allowed dosage limitations and formulations, and expand patient access and reduce patient cost by adding nurse practitioners and physician assistants to the list of those authorized to issue written certifications to patients. Marijuana policy should be evidence based.

Policy 180

Policy Patients Education Legislation 180

FloridaMarijuana.net

AUGUST 15, 2018

Most commonly, patients report that tingling and numbness occur, usually in the hands and feet. Six trials that included 325 patients examined chronic pain, 6 trials that included 396 patients investigated neuropathic pain, and 12 trials that included 1600 patients focused on multiple sclerosis.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150